Annual long term debt:
$2.25B-$270.01M(-10.70%)Summary
- As of today (September 18, 2025), AMRX annual long term debt is $2.25 billion, with the most recent change of -$270.01 million (-10.70%) on December 31, 2024.
- During the last 3 years, AMRX annual long term debt has fallen by -$577.13 million (-20.39%).
- AMRX annual long term debt is now -21.98% below its all-time high of $2.89 billion, reached on December 31, 2020.
Performance
AMRX Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$2.25B+$4.53M(+0.20%)Summary
- As of today (September 18, 2025), AMRX quarterly long term debt is $2.25 billion, with the most recent change of +$4.53 million (+0.20%) on June 30, 2025.
- Over the past year, AMRX quarterly long term debt has dropped by -$27.01 million (-1.19%).
- AMRX quarterly long term debt is now -23.39% below its all-time high of $2.93 billion, reached on March 31, 2020.
Performance
AMRX Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
AMRX Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.7% | -1.2% |
| 3 y3 years | -20.4% | -18.8% |
| 5 y5 years | -17.4% | -23.3% |
AMRX Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.4% | at low | -18.8% | +0.2% |
| 5 y | 5-year | -22.0% | at low | -23.3% | +0.2% |
| alltime | all time | -22.0% | >+9999.0% | -23.4% | >+9999.0% |
AMRX Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.25B(+0.2%) |
| Mar 2025 | - | $2.24B(-0.5%) |
| Dec 2024 | $2.25B(-10.7%) | $2.25B(-0.5%) |
| Sep 2024 | - | $2.26B(-0.4%) |
| Jun 2024 | - | $2.27B(-9.7%) |
| Mar 2024 | - | $2.52B(-0.2%) |
| Dec 2023 | $2.52B(-7.9%) | $2.52B(-5.9%) |
| Sep 2023 | - | $2.68B(-0.4%) |
| Jun 2023 | - | $2.69B(-0.6%) |
| Mar 2023 | - | $2.71B(-1.2%) |
| Dec 2022 | $2.74B(-3.2%) | $2.74B(-0.4%) |
| Sep 2022 | - | $2.75B(-0.6%) |
| Jun 2022 | - | $2.77B(-1.9%) |
| Mar 2022 | - | $2.82B(-0.4%) |
| Dec 2021 | $2.83B(-2.0%) | $2.83B(-0.3%) |
| Sep 2021 | - | $2.84B(-1.2%) |
| Jun 2021 | - | $2.87B(-0.1%) |
| Mar 2021 | - | $2.88B(-0.3%) |
| Dec 2020 | $2.89B(+5.8%) | $2.89B(-0.9%) |
| Sep 2020 | - | $2.92B(-0.4%) |
| Jun 2020 | - | $2.93B(-0.2%) |
| Mar 2020 | - | $2.93B(+7.5%) |
| Dec 2019 | $2.73B(+2.2%) | $2.73B(-0.2%) |
| Sep 2019 | - | $2.73B(-0.4%) |
| Jun 2019 | - | $2.74B(-0.3%) |
| Mar 2019 | - | $2.75B(+3.2%) |
| Dec 2018 | $2.67B(+91.3%) | $2.67B(-0.2%) |
| Sep 2018 | - | $2.68B(-0.2%) |
| Jun 2018 | - | $2.68B(>+9900.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $1.40B(+71.5%) | $1.40B(+71.5%) |
| Dec 2016 | $813.54M(+91.6%) | - |
| Dec 2016 | - | $813.54M(+0.1%) |
| Sep 2016 | - | $812.38M(+86.6%) |
| Jun 2016 | - | $435.26M(+1.3%) |
| Mar 2016 | - | $429.88M(+1.2%) |
| Dec 2015 | $424.60M(>+9900.0%) | $424.60M(-20.0%) |
| Sep 2015 | - | $530.41M(-8.8%) |
| Jun 2015 | - | $581.39M(+45.9%) |
| Mar 2015 | - | $398.61M(>+9900.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(-100.0%) |
| Jun 2009 | - | $5.07M(-8.4%) |
| Mar 2009 | - | $5.53M(-7.7%) |
| Dec 2008 | $5.99M(-70.8%) | $5.99M(-7.0%) |
| Sep 2008 | - | $6.44M(-67.3%) |
| Jun 2008 | - | $19.70M(-4.0%) |
| Dec 2007 | $20.51M(-77.1%) | $20.51M(-77.1%) |
| Dec 2006 | $89.60M(+11.6%) | $89.60M(+1130.1%) |
| Dec 2005 | $80.28M(+390.9%) | - |
| Sep 2004 | - | $7.28M(-3.0%) |
| Jun 2004 | - | $7.51M(-11.6%) |
| Mar 2004 | - | $8.49M(-48.1%) |
| Dec 2003 | $16.35M(-1.5%) | $16.35M(+81.0%) |
| Sep 2003 | - | $9.04M(-3.8%) |
| Jun 2003 | - | $9.39M(-2.6%) |
| Mar 2003 | - | $9.64M(-41.9%) |
| Dec 2002 | $16.61M(+141.8%) | $16.61M(+17.0%) |
| Sep 2002 | - | $14.20M(-62.6%) |
| Jun 2002 | - | $38.00M(+1.0%) |
| Mar 2002 | - | $37.61M(+447.6%) |
| Dec 2001 | $6.87M(+410.6%) | $6.87M(+86.0%) |
| Sep 2001 | - | $3.69M(-85.6%) |
| Jun 2001 | - | $25.73M(+1864.0%) |
| Mar 2001 | - | $1.31M(-2.6%) |
| Dec 2000 | $1.34M(-9.7%) | $1.34M(-1.2%) |
| Sep 2000 | - | $1.36M(-3.1%) |
| Jun 2000 | - | $1.41M(-3.0%) |
| Mar 2000 | - | $1.45M(-2.8%) |
| Dec 1999 | $1.49M(-24.3%) | $1.49M(-18.8%) |
| Sep 1999 | - | $1.84M(-2.1%) |
| Jun 1999 | - | $1.88M(-2.2%) |
| Mar 1999 | - | $1.92M(-2.5%) |
| Dec 1998 | $1.97M | $1.97M(-2.0%) |
| Sep 1998 | - | $2.01M(-2.1%) |
| Jun 1998 | - | $2.05M(-1.9%) |
| Mar 1998 | - | $2.09M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual long term debt?
- What is the all time high annual long term debt for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual long term debt year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly long term debt?
- What is the all time high quarterly long term debt for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly long term debt year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual long term debt?
The current annual long term debt of AMRX is $2.25B
What is the all time high annual long term debt for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual long term debt is $2.89B
What is Amneal Pharmaceuticals, Inc. annual long term debt year-on-year change?
Over the past year, AMRX annual long term debt has changed by -$270.01M (-10.70%)
What is Amneal Pharmaceuticals, Inc. quarterly long term debt?
The current quarterly long term debt of AMRX is $2.25B
What is the all time high quarterly long term debt for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly long term debt is $2.93B
What is Amneal Pharmaceuticals, Inc. quarterly long term debt year-on-year change?
Over the past year, AMRX quarterly long term debt has changed by -$27.01M (-1.19%)